Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events "CHANCE"


Phase 3 Results N/A



  • Wang Y, Johnston SC; CHANCE Investigators. Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. Am Heart J. 2010 Sep;160(3):380-386.e1. Pubmed ID:20826243
  • Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol. 2007 May;6(5):456-64. Review. Pubmed ID:17434100

Related Links

Sources for Trial Information

  • Ministry of Science and Technology of the PeopleĀ“s Republic of China